Published by Iain Gilbert on 17th August 2026
(Sharecast News) - Drugmaker AstraZeneca posted two contrasting lung‑cancer updates on Monday, discontinuing one Phase III study while reporting strong survival gains from another.
URL: http://www.digitallook.com/dl/news/story/36144133/...